June 5, 2026
Shroom Boom vs Doom
Alzheimer's patient gets back speech, bladder control and memory in drug trial
Magic mushroom miracle or clickbait? Commenters instantly split into skeptics vs source-droppers
TLDR: A case study says an Alzheimer’s patient briefly regained speech and bladder control after psilocybin, suggesting some lost function may be harder to reach, not fully gone. Commenters instantly turned it into a trust battle: one side called the story sketchy, the other rushed in with the original research link.
The science story is wild enough on its own: an 80-year-old woman with advanced Alzheimer’s reportedly regained speech, bladder control, eye contact, humor, and some memory after doses of psilocybin, the compound found in magic mushrooms. For a disease most people associate with a one-way slide, that’s the kind of headline that makes the internet do a double take — and the comment section did exactly that.
But the real drama? Trust issues, immediately. One of the loudest reactions wasn’t even about the mushrooms — it was about the source. “New York Post? Yeah I don't think so...” basically set the mood for the skeptics, who treated the story like a too-good-to-be-true miracle tale. Then came the classic internet counterpunch: a receipts guy dropping the original manuscript, turning the comments into a mini showdown between headline doubters and paper-link posters.
That clash became the whole vibe: one side saying, “This sounds bananas,” the other saying, “Here’s the actual study, read before you sneer.” And to be fair, the study itself throws some cold water on the hype: this was one patient, the improvement was temporary, and researchers are not claiming Alzheimer’s was reversed. Still, the idea that lost abilities might be inaccessible rather than gone had readers doing the internet equivalent of raising one eyebrow and opening ten tabs. In other words: part miracle, part mushroom, part media distrust — pure comment-section catnip.
Key Points
- •The article describes a case study of an 80-year-old woman with advanced Alzheimer’s disease who showed temporary functional improvements after psilocybin treatment.
- •After a 5-gram dose, the patient reportedly progressed from agitation and prolonged sleep-like unresponsiveness to speaking in full sentences and recalling past events.
- •The article says subsequent improvements included regained urinary continence, better eye contact, more lucid conversation, emotional responsiveness, and some self-care abilities.
- •A later 3-gram dose was followed by increased verbal expression, humor, and improved walking agility, according to the article.
- •The article emphasizes that the reported benefits were temporary, did not reverse neurodegeneration, and came from a single-patient study with important limitations.